Photo of Erica Mayer taken from Dana-Farber Cancer Institute/LinkedIn
May 23, 2024, 10:28
In a recent interview Dr. Erica Mayer discussed tamoxifen and aromatase inhibitors – Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X:
“In a recent Health Reporter interview Dr. Erica Mayer discussed tamoxifen and aromatase inhibitors and offered ways to manage side effects that may interfere with breast cancer patients’ daily life.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 17:57
Nov 14, 2024, 17:46
Nov 14, 2024, 17:46
Nov 14, 2024, 17:42
Nov 14, 2024, 17:14